What You Should Know
– As Americans set their sights on a healthier 2024, a new survey by DrFirst’s iPrescribe app reveals some interesting trends in health priorities and concerns.
– While traditional resolutions like exercising…
Continue Reading
Advancements in AI-driven healthcare and pharmaceuticals are reshaping the industry, evident through recent funding and collaborations. Peptris Technologies, backed by $1 million, expands AI drug discovery to rare diseases. Cipla boosts its stake in…
Continue Reading
AI revolutionizes healthcare through precise medical imaging, AI-assisted surgeries, accelerated research, drug development, and early disease detection. Remote patient care, fraud prevention, accurate cancer diagnosis, and gene editing are redefining healthcare standards. Collaboration between…
Continue Reading
The emergence of artificial intelligence (AI) in healthcare is the result of increased demand for tailored healthcare solutions, lower costs, higher accuracy pertaining to medical decisions and diagnosis to improve patient health outcomes. With an…
Continue Reading
Telehealth and AI merge to optimize care pathways, aiding patient triage and remote diagnosis. Piotr Orzechowski, CEO of Infermedica, elucidates AI’s role in telemedicine advancement, addressing care uncertainties and boosting healthcare efficiency. Integrating AI-powered…
Continue Reading
Telemedicine took a huge leap forward during the pandemic as more providers and patients embraced remote delivery of healthcare services.Today, artificial intelligence-powered telemedicine tools that remotely diagnose patients and route them to the proper…
Continue Reading
GE Healthcare’s Critical Care Suite 2.1, now with FDA-cleared Pneumothorax (PTX) detection, offers on-device AI for rapid triage and diagnosis. This innovation enhances bedside X-ray capabilities, aiding clinicians in prompt PTX identification, notification, and…
Continue Reading
Bering Limited’s achievement of FDA clearance for BraveCX, an AI-powered chest X-ray triage tool, represents a significant breakthrough in the field of medical technology. This milestone not only underscores the company’s commitment to innovation…
Continue Reading
Philochem and Blue Earth Diagnostics celebrate a pivotal advancement in their collaboration, initiating a Phase 1 Clinical Trial with 68Ga-OncoFAP for imaging solid tumors. This partnership aims to explore OncoFAP, a specialized ligand targeting…
Continue Reading
A study done by Google Research in collaboration with Google DeepMind reveals the tech giant developed an LLM with conversational and collaborative capabilities that can provide an accurate differential diagnosis (DDx) and help improve…
Continue Reading
